22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release
here
Home
About Us
Our Company
Our Leadership Team
Board of Directors
Reduced Nicotine Tobacco
VLN®
Clinical Studies & Commentaries
Hemp/Cannabis Innovation
GVB Biopharma
Hops Research
News
Investors
Overview
New Investor / Latest Resources
Events
News
Stock Data
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
Contact Us
Press Releases
Investors
Investors
Overview
New Investor / Latest Resources
Events
News
Press Releases
Stock Data
Quote
Charts
Historical Data
Trades
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
News
Press Releases
Year
All Years
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Category
All Releases
Financial Releases
Search terms
Search News
Apr 22, 2011 10:10am EDT
Company Profile for 22nd Century Group, Inc.
Prev
1...
27
28
29
30
31
32
33
34
35
36
Email Alerts
Contact
RSS News Feed
